Breaking News Instant updates and real-time market news.

SAGE

Sage Therapeutics

$147.45

1.795 (1.23%)

06:32
08/07/18
08/07
06:32
08/07/18
06:32

Sage Therapeutics reports Q2 EPS (36c), consensus ($1.89)

Reports Q2 revenue $90.0M, consensus $0. All Q2 revenues are attributable to an upfront payment from Sage's strategic collaboration with Shionogi & Co.

  • 07

    Aug

SAGE Sage Therapeutics
$147.45

1.795 (1.23%)

06/13/18
ADAM
06/13/18
NO CHANGE
Target $220
ADAM
Buy
Sage Therapeutics price target raised to $220 from $210 at Canaccord
Canaccord analyst Sumant Kulkarni raised his price target on Sage Therapeutics to $220 from $210 after the company announced it had a positive breakthrough meeting with the FDA on Sage-217, an oral drug being developed for postpartum depression, major depressive disorder and other psychiatric indications. Kulkarni believes the MDD indication is the main stock driver and he views the developments as very encouraging. Kulkarni reiterated his Buy rating on Sage shares.
06/13/18
JEFF
06/13/18
NO CHANGE
Target $9
JEFF
Buy
Sage update yesterday positive for Xenon, says Jefferies
Jefferies analyst Maury Raycroft believes Sage Therapeutics' (SAGE) FDA approval to accelerate a development path for '217 in major depressive disorder and postpartum depression provides a positive read-through for Xenon Pharmaceuticals (XENE). Xenon has two epilepsy programs and one program for hemiplegic migraine, which all have potential in rare disease indications with broader applicability, Raycroft tells investors in a research note. He believes "recent derisking" provides a "great entry point" into Xenon Pharmaceuticals at current share levels. The analyst has a Buy rating on the shares with a $9 price target.
08/06/18
PIPR
08/06/18
INITIATION
Target $206
PIPR
Overweight
Sage Therapeutics initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Danielle Brill started Sage Therapeutics with an Overweight rating and $206 price target. The analyst thinks Sage is on course to becoming a leader in central nervous system therapeutics. Its lead compound, IV brexanolone, is on track to becoming the first FDA approved therapy for postpartum depression by the end of 2018, Brill tells investors in a research note.
08/06/18
08/06/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Global Blood Therapeutics (GBT) initiated with an Overweight at Piper Jaffray. 2. Welltower (WELL) reinstated with a Neutral at Goldman Sachs. 3. Sage Therapeutics (SAGE) initiated with an Overweight at Piper Jaffray. 4. SoftBank (SFTBY) initiated with a Buy at UBS. 5. Alder Biopharmaceuticals (ALDR) initiated with an Overweight at Piper Jaffray. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

NEPT

Neptune Wellness

$3.31

-0.03 (-0.90%)

15:19
11/13/18
11/13
15:19
11/13/18
15:19
Options
Neptune Technologies options imply 19.0% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
11/13/18
11/13
15:17
11/13/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$15.73

-4.1 (-20.68%)

15:16
11/13/18
11/13
15:16
11/13/18
15:16
Recommendations
Amarin analyst commentary  »

Physicians not concerned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
11/13/18
11/13
15:16
11/13/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$179.85

0.34 (0.19%)

15:16
11/13/18
11/13
15:16
11/13/18
15:16
Recommendations
Home Depot analyst commentary  »

Home Depot price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

FB

Facebook

$142.51

0.99 (0.70%)

15:11
11/13/18
11/13
15:11
11/13/18
15:11
Hot Stocks
Facebook took down 141 accounts following FBI tip »

Facebook said that last…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

THC

Tenet

$23.33

-2.39 (-9.29%)

15:10
11/13/18
11/13
15:10
11/13/18
15:10
Options
$2M call buy in Tenet Healthcare as shares lose 9% »

$2M call buy in Tenet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

15:10
11/13/18
11/13
15:10
11/13/18
15:10
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

AMC

AMC Entertainment

$15.49

0.3 (1.98%)

15:08
11/13/18
11/13
15:08
11/13/18
15:08
Recommendations
AMC Entertainment analyst commentary  »

AMC seeing success with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

  • 04

    Dec

AAWW

Atlas Air

$55.19

2.03 (3.82%)

15:05
11/13/18
11/13
15:05
11/13/18
15:05
Hot Stocks
Atlas Air, Southern Air announce pathway program agreement with Ameriflight »

Atlas Air Worldwide…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIX

Wix.com

$90.46

1.99 (2.25%)

15:04
11/13/18
11/13
15:04
11/13/18
15:04
Options
Wix.com options imply 18.0% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

ECA

Encana

$8.10

-0.31 (-3.69%)

15:00
11/13/18
11/13
15:00
11/13/18
15:00
Options
Encana option volume hits year high as shares touch year lows »

Encana option volume hits…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QRVO

Qorvo

$63.45

-0.35 (-0.55%)

, AAPL

Apple

$193.43

-0.725 (-0.37%)

14:51
11/13/18
11/13
14:51
11/13/18
14:51
Recommendations
Qorvo, Apple, Lumentum, Skyworks, Cirrus Logic, Broadcom analyst commentary  »

After Qorvo warns, MKM…

QRVO

Qorvo

$63.45

-0.35 (-0.55%)

AAPL

Apple

$193.43

-0.725 (-0.37%)

LITE

Lumentum

$38.92

1.415 (3.77%)

SWKS

Skyworks

$72.16

-0.61 (-0.84%)

CRUS

Cirrus Logic

$37.63

1.99 (5.58%)

AVGO

Broadcom

$224.39

0.84 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 19

    Nov

  • 06

    Dec

QRVO

Qorvo

$63.36

-0.44 (-0.69%)

, AAPL

Apple

$193.50

-0.655 (-0.34%)

14:51
11/13/18
11/13
14:51
11/13/18
14:51
Recommendations
Qorvo, Apple analyst commentary  »

JPMorgan sees…

QRVO

Qorvo

$63.36

-0.44 (-0.69%)

AAPL

Apple

$193.50

-0.655 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

AMRS

Amyris

$6.05

0.19 (3.24%)

14:49
11/13/18
11/13
14:49
11/13/18
14:49
Options
Amyris options imply 19.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

BA

Boeing

$347.91

-9.02 (-2.53%)

14:46
11/13/18
11/13
14:46
11/13/18
14:46
Periodicals
Pilots claim Boeing Lion Air crash linked to improper training, FT reports »

Pilot associations said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$193.31

-0.845 (-0.44%)

14:45
11/13/18
11/13
14:45
11/13/18
14:45
Technical Analysis
Technical Take: Apple moves lower after rally fails »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

XLK

Technology Select Sector SPDR

$67.49

0.08 (0.12%)

14:40
11/13/18
11/13
14:40
11/13/18
14:40
Options
Aggressive call buying in SPDR Tech Fund »

Aggressive call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QRVO

Qorvo

, AAPL

Apple

$192.80

-1.355 (-0.70%)

14:37
11/13/18
11/13
14:37
11/13/18
14:37
Recommendations
Qorvo, Apple analyst commentary  »

Qorvo price target…

QRVO

Qorvo

AAPL

Apple

$192.80

-1.355 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

TEUM

Pareteum

$1.87

-0.26 (-12.21%)

, IPAS

iPass

$1.14

(0.00%)

14:37
11/13/18
11/13
14:37
11/13/18
14:37
Recommendations
Pareteum, iPass analyst commentary  »

Pareteum price target…

TEUM

Pareteum

$1.87

-0.26 (-12.21%)

IPAS

iPass

$1.14

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

CF

CF Industries

$50.26

-1.03 (-2.01%)

14:35
11/13/18
11/13
14:35
11/13/18
14:35
Options
CF Industries put volume heavy and directionally bearish »

Bearish flow noted in CF…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

LVS

Las Vegas Sands

$51.96

0.995 (1.95%)

14:25
11/13/18
11/13
14:25
11/13/18
14:25
Options
Las Vegas Sands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:25
11/13/18
11/13
14:25
11/13/18
14:25
General news
Treasury Action: yields remained remained lower »

Treasury Action: yields…

VOYA

Voya Financial

$45.49

0.905 (2.03%)

14:24
11/13/18
11/13
14:24
11/13/18
14:24
Recommendations
Voya Financial analyst commentary  »

Voya Financial updated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
11/13/18
11/13
14:17
11/13/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.